Clinical Trials Logo

Clinical Trial Summary

The study consists in the retrospective and prospective collection of imaging data (along with clinical information related to treatment) of skull-base chordoma patients treated with particle therapy, to derive imaging biomarkers which, integrated with advanced mathematical models, will allow predicting treatment outcome on a multi-scale basis.


Clinical Trial Description

The study design consists of the retrospective collection of routinely-acquired data (CT, MRI and dose maps, along with relevant clinical information) and the prospective acquisition of optimized non-invasive MR imaging data, of skull-based chordoma patients treated with particle therapy (PT) at the National Center for Oncological Hadrontherapy (CNAO, Pavia, Italy). This data will be stored in a proper repository under CNAO's control, shared with Politecnico di Milano through encrypted channels, and it will be used to implement mathematical models able to predict treatment outcome at different scales (macroscopic, microscopic and radiobiological). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05888064
Study type Observational
Source CNAO National Center of Oncological Hadrontherapy
Contact Alberto Iannalfi, MD
Phone 0382078501
Email alberto.iannalfi@cnao.it
Status Recruiting
Phase
Start date April 19, 2022
Completion date April 18, 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02802969 - Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers Phase 2